Canada markets closed

Agilent Technologies, Inc. (A)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
146.09-1.39 (-0.94%)
At close: 04:00PM EDT
145.43 -0.66 (-0.45%)
After hours: 06:40PM EDT

Agilent Technologies, Inc.

5301 Stevens Creek Boulevard
Santa Clara, CA 95051
United States
800 227 9770
https://www.agilent.com

Sector(s)Healthcare
IndustryDiagnostics & Research
Full Time Employees17,700

Key Executives

NameTitlePayExercisedYear Born
Mr. Michael R. McMullenCEO, President & Director1.91M16.94M1961
Mr. Robert W. McMahonSenior VP, CFO and Interim President of Diagnostics & Genomics Group1.08MN/A1969
Mr. Padraig McDonnellChief Operating Officer1.06MN/AN/A
Mr. Henrik Ancher-JensenSenior VP and President of Order Fulfillment & Supply Chain927.44kN/A1965
Mr. Rodney GonsalvesPrincipal Accounting Officer, VP & Corporate ControllerN/AN/A1966
Mr. John KohlSenior Vice President & Chief Information OfficerN/AN/AN/A
Ms. P. Diana ChiuVP, Interim General Counsel & SecretaryN/AN/AN/A
Mr. Dominique P. GrauSenior Vice President of Human Resources & Global Communications936.31kN/A1959
Ms. Allison BallmerSenior Vice President of Strategy & Corporate DevelopmentN/AN/AN/A
Ms. Yvonne MackieMD of UK & Ireland Operations and VP of Human Resources - EuropeN/AN/AN/A
Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies. The Diagnostics and Genomics segment focuses on genomics, nucleic acid contract manufacturing and research and development, pathology, companion diagnostics, reagent partnership, and biomolecular analysis businesses. The Agilent CrossLab segment provides GC and LC columns, sample preparation products, custom chemistries, and laboratory instrument supplies; and offers services portfolio, including repairs, parts, maintenance, installations, training, compliance support, software as a service, asset management, and consulting services. The company markets its products through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce. Agilent Technologies, Inc. was incorporated in 1999 and is headquartered in Santa Clara, California.

Corporate Governance

Agilent Technologies, Inc.’s ISS Governance QualityScore as of March 1, 2024 is 7. The pillar scores are Audit: 8; Board: 3; Shareholder Rights: 9; Compensation: 2.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.